Abbott Laboratories (NYSE: ABT) shares experienced a significant upward move in early trading on Tuesday, catching the attention of investors across the United States. As of 9:54:46 AM EDT, shortly after the market opened, the healthcare giant’s stock was trading at $131.79.
This price represents a substantial gain of +$5.57, translating to a +4.42% increase for the session so far. The positive momentum marks a strong start to the trading day, pushing the stock well above its previous closing price of $126.22.
Today’s trading activity has seen ABT shares fluctuate within a range of $129.92 to $133.26. The stock opened the session at $129.70, indicating immediate buying interest at the bell. The intraday chart shows a sharp spike upwards around the 9:30 AM market open, sustaining levels significantly higher than those seen in pre-market or the previous day’s close.
Volume early in the session was recorded at 1,668,641 shares traded, which is on track relative to its average volume of 7,476,760 shares, suggesting active participation from traders. Abbott Laboratories currently boasts an intraday market capitalization of approximately $227.543 billion.
From a valuation perspective, ABT carries a Price-to-Earnings (PE) ratio (TTM) of 17.17, with Earnings Per Share (EPS) (TTM) standing at $7.64. The stock’s Beta over a 5-year monthly period is 0.80, suggesting slightly lower volatility compared to the broader market.
Investors looking at the longer term might note the stock’s 52-week range, spanning from $99.71 to $141.23. Today’s price action pushes it towards the upper end of this range. Furthermore, Abbott offers a forward dividend of $2.36, yielding 1.87%, with the next ex-dividend date noted as April 15, 2025. The consensus 1-year target estimate for ABT sits at $136.68, slightly above the current trading level. The next scheduled earnings report date is anticipated for April 16, 2025.
